ST人福(600079.SH)子公司注射用HWS113获得药物临床试验批准通知书

智通财经06-25

智通财经APP讯，ST人福(600079.SH)发布公告，公司全资子公司湖北生物医药产业技术研究院有限公司近日收到国家药品监督管理局核准签发的注射用HWS113的《药物临床试验批准通知书》。

据悉，注射用HWS113是一款治疗用生物制品1类新药，拟用于慢性瘙痒的治疗。慢性瘙痒定义为瘙痒持续超过6周，其严重影响患者的生活质量，导致睡眠障碍、影响社交与工作，引起焦虑或抑郁等负面心理问题。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2646873824?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-25 16:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646873824","market":"fut","top_or_hot":-1,"title":"ST人福(600079.SH)子公司注射用HWS113获得药物临床试验批准通知书","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/600079\">ST人福</a>(600079.SH)发布公告，公司全资子公司湖北生物医药产业技术研究院有限公司近日收到国家药品监督管理局核准签发的注射用HWS113的《药物临床试验批准通知书》。</p><p>据悉，注射用HWS113是一款治疗用生物制品1类新药，拟用于慢性瘙痒的治疗。慢性瘙痒定义为瘙痒持续超过6周，其严重影响患者的生活质量，导致睡眠障碍、影响社交与工作，引起焦虑或抑郁等负面心理问题。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ST人福(600079.SH)子公司注射用HWS113获得药物临床试验批准通知书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nST人福(600079.SH)子公司注射用HWS113获得药物临床试验批准通知书\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/600079\">ST人福</a>(600079.SH)发布公告，公司全资子公司湖北生物医药产业技术研究院有限公司近日收到国家药品监督管理局核准签发的注射用HWS113的《药物临床试验批准通知书》。</p><p>据悉，注射用HWS113是一款治疗用生物制品1类新药，拟用于慢性瘙痒的治疗。慢性瘙痒定义为瘙痒持续超过6周，其严重影响患者的生活质量，导致睡眠障碍、影响社交与工作，引起焦虑或抑郁等负面心理问题。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1458642.html\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1458642.html","article_id":"2646873824","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2646873824","pubTimestamp":1782375912,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，ST人福(600079.SH)发布公告，公司全资子公司湖北生物医药产业技术研究院有限公司近日收到国家药品监督管理局核准签发的注射用HWS113的《药物临床试验批准通知书》。据悉，注射用HWS113是一款治疗用生物制品1类新药，拟用于慢性瘙痒的治疗。慢性瘙痒定义为瘙痒持续超过6周，其严重影响患者的生活质量，导致睡眠障碍、影响社交与工作，引起焦虑或抑郁等负面心理问题。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600079":"ST人福","BK0028":"国家队","BK0239":"医药制造","BK0185":"二线龙头","BK0188":"融资融券","BK0012":"证金概念","BK0096":"民营医院","BK0070":"员工持股"},"translate_title":"ST Renfu (600079.SH) Subsidiary HWS113 for Injection Obtained Drug Clinical Trial Approval Notice","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600079":1.5},"content_text":"智通财经APP讯，ST人福(600079.SH)发布公告，公司全资子公司湖北生物医药产业技术研究院有限公司近日收到国家药品监督管理局核准签发的注射用HWS113的《药物临床试验批准通知书》。据悉，注射用HWS113是一款治疗用生物制品1类新药，拟用于慢性瘙痒的治疗。慢性瘙痒定义为瘙痒持续超过6周，其严重影响患者的生活质量，导致睡眠障碍、影响社交与工作，引起焦虑或抑郁等负面心理问题。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2646873824","isCrawlerRequest":true}